Stephen Eisennagel

Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis.

B. Tomczuk, J. Spurlino, Tianbao Lu, 2004, Bioorganic & medicinal chemistry letters.